MicroRNA-155 plays selective cell-intrinsic roles in brain-infiltrating immune cell populations during neuroinflammation

dc.contributor.author Thompson, J.W.
dc.contributor.author Hu, R.
dc.contributor.author Huffaker, T.B.
dc.contributor.author Ramstead, A.G.
dc.contributor.author Ekiz, Hüseyin Atakan
dc.contributor.author Bauer, K.M.
dc.contributor.author Tang, W.W.
dc.date.accessioned 2023-04-19T12:39:45Z
dc.date.available 2023-04-19T12:39:45Z
dc.date.issued 2023
dc.description.abstract The proinflammatory microRNA-155 (miR-155) is highly expressed in the serum and CNS lesions of patients with multiple sclerosis (MS). Global knockout (KO) of miR-155 in mice confers resistance to a mouse model of MS, experimental autoimmune encephalomyelitis (EAE), by reducing the encephalogenic potential of CNS-infiltrating Th17 T cells. However, cell-intrinsic roles for miR-155 during EAE have not been formally determined. In this study, we use single-cell RNA sequencing and cell-specific conditional miR-155 KOs to determine the importance of miR-155 expression in distinct immune cell populations. Time-course single-cell sequencing revealed reductions in T cells, macrophages, and dendritic cells (DCs) in global miR-155 KO mice compared with wild-type controls at day 21 after EAE induction. Deletion of miR-155 in T cells, driven by CD4 Cre, significantly reduced disease severity similar to global miR-155 KOs. CD11c Cre-mediated deletion of miR-155 in DCs also resulted in a modest yet significant reduction in the development of EAE, with both T cell- and DC-specific KOs showing a reduction in Th17 T cell infiltration into the CNS. Although miR-155 is highly expressed in infiltrating macrophages during EAE, deletion of miR-155 using LysM Cre did not impact disease severity. Taken together, these data show that although miR-155 is highly expressed in most infiltrating immune cells, miR-155 has distinct roles and requirements depending on the cell type, and we have demonstrated this using the gold standard conditional KO approach. This provides insights into which functionally relevant cell types should be targeted by the next generation of miRNA therapeutics. Copyright © 2023 by The American Association of Immunologists, Inc. en_US
dc.description.sponsorship National Institutes of Health, NIH; National Institute of Neurological Disorders and Stroke, NINDS: 5T32NS115664-02; National Multiple Sclerosis Society, NMSS en_US
dc.description.sponsorship This work was supported by the National Multiple Sclerosis Society collaborative center grant (to R.M.O. and J.L.R.) and the National Institutes of Health, National Institute of Neurological Disorders and Stroke T32 training grant (5T32NS115664-02 to J.W.T.). en_US
dc.identifier.doi 10.4049/jimmunol.2200478
dc.identifier.issn 0022-1767
dc.identifier.issn 1550-6606
dc.identifier.scopus 2-s2.0-85151043861
dc.identifier.uri https://doi.org/10.4049/jimmunol.2200478
dc.identifier.uri https://hdl.handle.net/11147/13395
dc.language.iso en en_US
dc.publisher American Association of Immunologists en_US
dc.relation.ispartof Journal of Immunology en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject microRNA en_US
dc.subject Mirn155 microRNA, mouse en_US
dc.subject animal en_US
dc.subject brain en_US
dc.subject C57BL mouse en_US
dc.subject experimental autoimmune encephalomyelitis en_US
dc.subject knockout mouse en_US
dc.subject metabolism en_US
dc.subject mouse en_US
dc.subject multiple sclerosis en_US
dc.subject pathology en_US
dc.subject Th17 cell en_US
dc.subject Animals en_US
dc.subject Brain en_US
dc.subject Encephalomyelitis, Autoimmune, Experimental en_US
dc.subject Mice en_US
dc.subject Mice, Inbred C57BL en_US
dc.subject Mice, Knockout en_US
dc.subject MicroRNAs en_US
dc.subject Multiple Sclerosis en_US
dc.subject Neuroinflammatory Diseases en_US
dc.subject Th17 Cells en_US
dc.title MicroRNA-155 plays selective cell-intrinsic roles in brain-infiltrating immune cell populations during neuroinflammation en_US
dc.type Article en_US
dspace.entity.type Publication
gdc.author.institutional Ekiz, Hüseyin Atakan
gdc.author.scopusid 57113941000
gdc.author.scopusid 55238191100
gdc.author.scopusid 55540553800
gdc.author.scopusid 53664253000
gdc.author.scopusid 36150568800
gdc.author.scopusid 57194053446
gdc.author.scopusid 57196482795
gdc.bip.impulseclass C4
gdc.bip.influenceclass C5
gdc.bip.popularityclass C4
gdc.coar.access metadata only access
gdc.coar.type text::journal::journal article
gdc.collaboration.industrial false
gdc.description.department İzmir Institute of Technology. Molecular Biology and Genetics en_US
gdc.description.departmenttemp Thompson, J.W., Department of Pathology, Division of Microbiology and Immunology, University of Utah, Salt Lake City, UT, United States; Hu, R., Department of Pathology, Division of Microbiology and Immunology, University of Utah, Salt Lake City, UT, United States; Huffaker, T.B., Department of Pathology, Division of Microbiology and Immunology, University of Utah, Salt Lake City, UT, United States; Ramstead, A.G., Department of Pathology, Division of Microbiology and Immunology, University of Utah, Salt Lake City, UT, United States; Ekiz, H.A., Izmir Institute of Technology, The Department of Molecular Biology and Genetics Gulbahce, Urla, Izmir, Turkey; Bauer, K.M., Department of Pathology, Division of Microbiology and Immunology, University of Utah, Salt Lake City, UT, United States; Tang, W.W., Department of Pathology, Division of Microbiology and Immunology, University of Utah, Salt Lake City, UT, United States; Ghazaryan, A., Department of Pathology, Division of Microbiology and Immunology, University of Utah, Salt Lake City, UT, United States; Round, J.L., Department of Pathology, Division of Microbiology and Immunology, University of Utah, Salt Lake City, UT, United States, Hunstman Cancer Institute, University of Utah, Salt en_US
gdc.description.endpage 934 en_US
gdc.description.issue 7 en_US
gdc.description.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
gdc.description.scopusquality Q2
gdc.description.startpage 926 en_US
gdc.description.volume 210 en_US
gdc.description.wosquality Q2
gdc.identifier.openalex W4323535718
gdc.identifier.pmid 36883849
gdc.identifier.wos WOS:001044690200013
gdc.index.type WoS
gdc.index.type Scopus
gdc.index.type PubMed
gdc.oaire.diamondjournal false
gdc.oaire.impulse 10.0
gdc.oaire.influence 2.9365166E-9
gdc.oaire.isgreen false
gdc.oaire.keywords Mice, Inbred C57BL
gdc.oaire.keywords Mice, Knockout
gdc.oaire.keywords Mice
gdc.oaire.keywords MicroRNAs
gdc.oaire.keywords Encephalomyelitis, Autoimmune, Experimental
gdc.oaire.keywords Multiple Sclerosis
gdc.oaire.keywords Neuroinflammatory Diseases
gdc.oaire.keywords Animals
gdc.oaire.keywords Th17 Cells
gdc.oaire.keywords Brain
gdc.oaire.popularity 8.189061E-9
gdc.oaire.publicfunded false
gdc.openalex.collaboration International
gdc.openalex.fwci 2.67102082
gdc.openalex.normalizedpercentile 0.91
gdc.openalex.toppercent TOP 10%
gdc.opencitations.count 8
gdc.plumx.crossrefcites 6
gdc.plumx.mendeley 11
gdc.plumx.newscount 1
gdc.plumx.pubmedcites 8
gdc.plumx.scopuscites 14
gdc.scopus.citedcount 14
gdc.wos.citedcount 11
relation.isAuthorOfPublication.latestForDiscovery 2c88cfb1-2fb0-4a65-bf64-8ed97df65431
relation.isOrgUnitOfPublication.latestForDiscovery 9af2b05f-28ac-4013-8abe-a4dfe192da5e

Files